Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694

Sort by:

3D Cell Culture Market by Product (Scaffold-based, Scaffold-free, Microfluidics-based, and Magnetic & Bioprinter), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Cosmetics Industry), By Geography (North America, Europe, APAC, and RoW) Global Opportunity Analysis and Industry Forecast up to 2026

US$ 3,250.00

3D Cell Culture Market by Product (Scaffold-based, Scaffold-free, Microfluidics-based, and Magnetic & Bioprinter), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End-User (Pharmaceut...

July 2020 130 pages

AI in Drug Discovery Market By Component (Software, Service), Technology (ML, DL), By Application (Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and Other Applications), By End User (Pharmaceutical & Biotechnology, CRO, and Research Centers and Academic & Government Institutes), By Geography (North America, Europe, APAC, and RoW) Global Opportunity Analysis and Industry Forecast up to 2026

US$ 3,250.00

AI in Drug Discovery Market By Component (Software, Service), Technology (ML, DL), By Application (Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and Other A...

July 2020 88 pages

Acne Vulgaris pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Acne Vulgaris PIPELINE HIGHLIGHTS Acne Vulgaris is one of the widely researched conditions during 2020 with 42 companies actively focusing on realizing pipeline’s potential. Development of Acne V...

July 2020 210 pages

Acromegaly pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Acromegaly PIPELINE HIGHLIGHTS Acromegaly is one of the widely researched conditions during 2020 with 22 companies actively focusing on realizing pipeline’s potential. Development of Acromegaly m...

July 2020 96 pages

Actinic Keratosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Actinic Keratosis PIPELINE HIGHLIGHTS Actinic Keratosis is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Development o...

July 2020 59 pages

Alcoholic Hepatitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Alcoholic Hepatitis PIPELINE HIGHLIGHTS Alcoholic Hepatitis is one of the widely researched conditions during 2020 with 14 companies actively focusing on realizing pipeline’s potential. Developme...

July 2020 72 pages

Alopecia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Alopecia PIPELINE HIGHLIGHTS Alopecia is one of the widely researched conditions during 2020 with 40 companies actively focusing on realizing pipeline’s potential. Development of Alopecia medicin...

July 2020 200 pages

Anemia in Chronic Kidney Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Anemia in Chronic Kidney Disease PIPELINE HIGHLIGHTS Anemia in Chronic Kidney Disease is one of the widely researched conditions during 2020 with 25 companies actively focusing on realizing pipel...

July 2020 124 pages

Angina (Angina Pectoris) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Angina (Angina Pectoris) PIPELINE HIGHLIGHTS Angina (Angina Pectoris) is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential....

July 2020 53 pages

Aplastic Anemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Aplastic Anemia PIPELINE HIGHLIGHTS Aplastic Anemia is one of the widely researched conditions during 2020 with 15 companies actively focusing on realizing pipeline’s potential. Development of Ap...

July 2020 84 pages

Arrhythmias pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Arrhythmias PIPELINE HIGHLIGHTS Arrhythmias is one of the widely researched conditions during 2020 with 15 companies actively focusing on realizing pipeline’s potential. Development of Arrhythmia...

July 2020 72 pages

Arterial Thrombosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Arterial Thrombosis PIPELINE HIGHLIGHTS Arterial Thrombosis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Developmen...

July 2020 48 pages

Atrial Fibrillation pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Atrial Fibrillation PIPELINE HIGHLIGHTS Atrial Fibrillation is one of the widely researched conditions during 2020 with 23 companies actively focusing on realizing pipeline’s potential. Developme...

July 2020 121 pages

Atypical Hemolytic Uremic Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Atypical Hemolytic Uremic Syndrome PIPELINE HIGHLIGHTS Atypical Hemolytic Uremic Syndrome is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pi...

July 2020 63 pages

Axillary Hyperhidrosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Axillary Hyperhidrosis PIPELINE HIGHLIGHTS Axillary Hyperhidrosis is one of the widely researched conditions during 2020 with 7 companies actively focusing on realizing pipeline’s potential. Deve...

July 2020 51 pages

Behcet Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Behcet Disease PIPELINE HIGHLIGHTS Behcet Disease is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Behce...

July 2020 47 pages

Bullous Pemphigoid pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Bullous Pemphigoid PIPELINE HIGHLIGHTS Bullous Pemphigoid is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 59 pages

Burns pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Burns PIPELINE HIGHLIGHTS Burns is one of the widely researched conditions during 2020 with 32 companies actively focusing on realizing pipeline’s potential. Development of Burns medicines is ide...

July 2020 146 pages

Celiac Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Celiac Disease PIPELINE HIGHLIGHTS Celiac Disease is one of the widely researched conditions during 2020 with 19 companies actively focusing on realizing pipeline’s potential. Development of Celi...

July 2020 89 pages

Colitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Colitis PIPELINE HIGHLIGHTS Colitis is one of the widely researched conditions during 2020 with 27 companies actively focusing on realizing pipeline’s potential. Development of Colitis medicines...

July 2020 112 pages

Constipation pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Constipation PIPELINE HIGHLIGHTS Constipation is one of the widely researched conditions during 2020 with 16 companies actively focusing on realizing pipeline’s potential. Development of Constipa...

July 2020 82 pages

Contact Dermatitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Contact Dermatitis PIPELINE HIGHLIGHTS Contact Dermatitis is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 40 pages

Contrast Induced Nephropathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Contrast Induced Nephropathy PIPELINE HIGHLIGHTS Contrast Induced Nephropathy is one of the widely researched conditions during 2020 with 3 companies actively focusing on realizing pipeline’s pot...

July 2020 35 pages

Coronary Artery Disease (CAD) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Coronary Artery Disease (CAD) PIPELINE HIGHLIGHTS Coronary Artery Disease (CAD) is one of the widely researched conditions during 2020 with 39 companies actively focusing on realizing pipeline’s...

July 2020 176 pages

Critical Limb Ischemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Critical Limb Ischemia PIPELINE HIGHLIGHTS Critical Limb Ischemia is one of the widely researched conditions during 2020 with 27 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 121 pages

Deep Vein Thrombosis (DVT) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Deep Vein Thrombosis (DVT) PIPELINE HIGHLIGHTS Deep Vein Thrombosis (DVT) is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potenti...

July 2020 46 pages

Diabetic Gastroparesis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Diabetic Gastroparesis PIPELINE HIGHLIGHTS Diabetic Gastroparesis is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 62 pages

Diarrhea pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Diarrhea PIPELINE HIGHLIGHTS Diarrhea is one of the widely researched conditions during 2020 with 29 companies actively focusing on realizing pipeline’s potential. Development of Diarrhea medicin...

July 2020 145 pages

Dilated Cardiomyopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Dilated Cardiomyopathy PIPELINE HIGHLIGHTS Dilated Cardiomyopathy is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Deve...

July 2020 54 pages

Down Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Down Syndrome PIPELINE HIGHLIGHTS Down Syndrome is one of the widely researched conditions during 2020 with 13 companies actively focusing on realizing pipeline’s potential. Development of Down S...

July 2020 75 pages

End Stage Kidney Disease (ESRD) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 End Stage Kidney Disease (ESRD) PIPELINE HIGHLIGHTS End Stage Kidney Disease (ESRD) is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline...

July 2020 52 pages

Enterocolitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Enterocolitis PIPELINE HIGHLIGHTS Enterocolitis is one of the widely researched conditions during 2020 with 11 companies actively focusing on realizing pipeline’s potential. Development of Entero...

July 2020 60 pages

Eosinophilic Esophagitis (EoE) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Eosinophilic Esophagitis (EoE) PIPELINE HIGHLIGHTS Eosinophilic Esophagitis (EoE) is one of the widely researched conditions during 2020 with 18 companies actively focusing on realizing pipeline’...

July 2020 79 pages

Epidermolysis Bullosa pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Epidermolysis Bullosa PIPELINE HIGHLIGHTS Epidermolysis Bullosa is one of the widely researched conditions during 2020 with 33 companies actively focusing on realizing pipeline’s potential. Devel...

July 2020 156 pages

Fanconi Anemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Fanconi Anemia PIPELINE HIGHLIGHTS Fanconi Anemia is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Fanco...

July 2020 50 pages

Functional Dyspepsia (Non Ulcer Dyspepsia) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Functional Dyspepsia (Non Ulcer Dyspepsia) PIPELINE HIGHLIGHTS Functional Dyspepsia (Non Ulcer Dyspepsia) is one of the widely researched conditions during 2020 with 4 companies actively focusing...

July 2020 42 pages

Gastric Ulcers pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Gastric Ulcers PIPELINE HIGHLIGHTS Gastric Ulcers is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Gastr...

July 2020 42 pages

Gastritis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Gastritis PIPELINE HIGHLIGHTS Gastritis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Gastritis medic...

July 2020 58 pages

Gastroenteritis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Gastroenteritis PIPELINE HIGHLIGHTS Gastroenteritis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Gas...

July 2020 58 pages

Gingivitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Gingivitis PIPELINE HIGHLIGHTS Gingivitis is one of the widely researched conditions during 2020 with 3 companies actively focusing on realizing pipeline’s potential. Development of Gingivitis me...

July 2020 35 pages

Graves Diseases pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Graves Diseases PIPELINE HIGHLIGHTS Graves Diseases is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Development of Gra...

July 2020 56 pages

Hepatic Encephalopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hepatic Encephalopathy PIPELINE HIGHLIGHTS Hepatic Encephalopathy is one of the widely researched conditions during 2020 with 12 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 79 pages

Hidradenitis Suppurativa pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hidradenitis Suppurativa PIPELINE HIGHLIGHTS Hidradenitis Suppurativa is one of the widely researched conditions during 2020 with 19 companies actively focusing on realizing pipeline’s potential....

July 2020 126 pages

Hives (Chronic Urticaria) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hives (Chronic Urticaria) PIPELINE HIGHLIGHTS Hives (Chronic Urticaria) is one of the widely researched conditions during 2020 with 25 companies actively focusing on realizing pipeline’s potentia...

July 2020 120 pages

Hypereosinophilic Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hypereosinophilic Syndrome PIPELINE HIGHLIGHTS Hypereosinophilic Syndrome is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potenti...

July 2020 48 pages

Hypertrophic Cardiomyopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hypertrophic Cardiomyopathy PIPELINE HIGHLIGHTS Hypertrophic Cardiomyopathy is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s poten...

July 2020 52 pages

Hypoparathyroidism pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hypoparathyroidism PIPELINE HIGHLIGHTS Hypoparathyroidism is one of the widely researched conditions during 2020 with 11 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 61 pages

Hypotension pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hypotension PIPELINE HIGHLIGHTS Hypotension is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Hypotension...

July 2020 48 pages

Hypothyroidism pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hypothyroidism PIPELINE HIGHLIGHTS Hypothyroidism is one of the widely researched conditions during 2020 with 7 companies actively focusing on realizing pipeline’s potential. Development of Hypot...

July 2020 48 pages

Idiopathic Thrombocytopenic Purpura (ITP) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Idiopathic Thrombocytopenic Purpura (ITP) PIPELINE HIGHLIGHTS Idiopathic Thrombocytopenic Purpura (ITP) is one of the widely researched conditions during 2020 with 23 companies actively focusing...

July 2020 104 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

Discount Offer from GMD Research

Special Offer from MP Advisors

Special Offer on Therapy Class R...